XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 21,763,615 $ 12,587,736 [1]
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on investments 2,671,714 (4,931,422)
Net change unrealized (appreciation) depreciation on derivative investments 587,496 0
Net change unrealized (appreciation) depreciation on foreign currency and other transactions (686,533)  
Net realized (gain) loss on investments (2,138,708) (913,214)
Net realized (gain) loss on foreign currency and other transactions 1,621 0
Payment-in-kind interest capitalized (3,380,583) (2,127,784)
Net accretion of discount and amortization of premium (4,778,617) (887,350)
Amortization of deferred financing costs 516,669 307,362
Amortization of offering costs 1,108,429 508,503
Purchases of investments (450,677,120) (413,366,059)
Proceeds from sale of investments and principal repayments 193,363,481 93,579,328
Changes in operating assets and liabilities:    
Interest receivable (4,878,770) (2,281,278)
Deferred offering costs (1,223,320) (561,946)
Receivable for investments sold (4,663,600) (10,944,123)
Due from Advisor 607,298 (171,526)
Other assets (13,347) (26,959)
Payable for investments purchased 23,891,032 30,543,395
Due to Advisor and affiliates (35,045) (789,969)
Management fee payable 457,129 676,482
Income incentive fee payable 643,020 0
Capital gains incentive fee payable (188,052) 747,254
Interest and credit facility fees payable 757,268 2,439,575
Accrued expenses and other liabilities 454,439 670,901
Net cash provided by (used in) operating activities (225,840,484) (294,941,094)
Cash flows from financing activities:    
Proceeds from Secured Credit Facility 83,016,000 170,000,000
Repayment of Secured Credit Facility 0 (25,000,000)
Deferred financing costs paid 0 (1,945,091)
Dividends paid in cash (11,358,764) (1,643,121)
Proceeds from issuance of common shares 157,391,157 208,601,300
Net cash provided by (used in) financing activities 229,048,393 350,013,088
Net increase (decrease) in cash and cash equivalents 3,207,909 55,071,994
Cash, cash equivalents and restricted cash, beginning of period 73,025,293 10,000
Cash, cash equivalents and restricted cash, end of period 76,233,202 55,081,994
Supplemental information and non-cash activities:    
Cash paid for interest 15,999,514 1,259,988
Reinvestment of distributions 19,888,261 5,536,831
Accrued but unpaid deferred offering cost $ 274,585 $ 0
[1] Common Shares issued during the three and nine months ended September 30, 2023 relate to the Private Offering and became Class I shares as part of Public Offering effective June 24, 2024. Common Shares issued pursuant to the Private Offering are presented as Class I to conform with current period presentation.